These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19029066)

  • 21. A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice.
    Jahagirdar R; Zhang H; Azhar S; Tobin J; Attwell S; Yu R; Wu J; McLure KG; Hansen HC; Wagner GS; Young PR; Srivastava RA; Wong NC; Johansson J
    Atherosclerosis; 2014 Sep; 236(1):91-100. PubMed ID: 25016363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varespladib: targeting the inflammatory face of atherosclerosis.
    Arsenault BJ; Boekholdt SM; Kastelein JJ
    Eur Heart J; 2011 Apr; 32(8):923-6. PubMed ID: 21112895
    [No Abstract]   [Full Text] [Related]  

  • 23. Statin therapy and secretory phospholipase A₂ in children with heterozygous familial hypercholesterolemia.
    Braamskamp MJ; Tsimikas S; Wiegman A; Kastelein JJ; Hutten BA
    Atherosclerosis; 2013 Aug; 229(2):404-7. PubMed ID: 23880195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic CGI-58 expression in macrophages alleviates the atherosclerotic lesion development in ApoE knockout mice.
    Xie P; Zeng X; Xiao J; Sun B; Yang D
    Biochim Biophys Acta; 2014 Dec; 1841(12):1683-90. PubMed ID: 25178844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
    Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pravastatin improves atherosclerosis in mice with hyperlipidemia by inhibiting TREM-1/DAP12.
    Wang HM; Gao JH; Lu JL
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4995-5003. PubMed ID: 30070336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice.
    Hartman HB; Gardell SJ; Petucci CJ; Wang S; Krueger JA; Evans MJ
    J Lipid Res; 2009 Jun; 50(6):1090-100. PubMed ID: 19174369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.
    Kim CH; Mitchell JB; Bursill CA; Sowers AL; Thetford A; Cook JA; van Reyk DM; Davies MJ
    Atherosclerosis; 2015 May; 240(1):234-41. PubMed ID: 25818249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of montelukast on atherogenesis in apoE/LDLR-double knockout mice.
    Jawien J; Gajda M; Wołkow P; Zurańska J; Olszanecki R; Korbut R
    J Physiol Pharmacol; 2008 Sep; 59(3):633-9. PubMed ID: 18953103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis.
    Jones GW; McLeod L; Kennedy CL; Bozinovski S; Najdovska M; Jenkins BJ
    Atherosclerosis; 2015 Feb; 238(2):321-8. PubMed ID: 25545330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thieno[2,3-c]isoquinolin-5-one, a potent poly(ADP-ribose) polymerase inhibitor, promotes atherosclerotic plaque regression in high-fat diet-fed apolipoprotein E-deficient mice: effects on inflammatory markers and lipid content.
    Hans CP; Zerfaoui M; Naura AS; Troxclair D; Strong JP; Matrougui K; Boulares AH
    J Pharmacol Exp Ther; 2009 Apr; 329(1):150-8. PubMed ID: 19124646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E.
    Yang H; Roberts LJ; Shi MJ; Zhou LC; Ballard BR; Richardson A; Guo ZM
    Circ Res; 2004 Nov; 95(11):1075-81. PubMed ID: 15528470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
    Wang Y; Zhao X; Jin H; Wei H; Li W; Bu D; Tang X; Ren Y; Tang C; Du J
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):173-9. PubMed ID: 18988885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E-deficient mice.
    Xu J; Ma C; Chen M; Rong S; Gao H; Xia Z; Huang F
    Lipids Health Dis; 2018 Jul; 17(1):182. PubMed ID: 30064511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Hama S; Hough G; Reddy ST; Frank JS; Garber DW; Handattu S; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1426-32. PubMed ID: 15845909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pravastatin attenuates the action of the ETS domain-containing protein ELK1 to prevent atherosclerosis in apolipoprotein E-knockout mice via modulation of extracellular signal-regulated kinase 1/2 signal pathway.
    Yan W; Li D; Zhou X
    Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):344-352. PubMed ID: 27998006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of some active ingredients of Chinese drugs for activating blood circulation and detoxicating on blood lipids and atherosclerotic plaque inflammatory reaction in ApoE-gene knockout mice].
    Zhou MX; Xu H; Chen KJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Feb; 28(2):126-30. PubMed ID: 18386574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of asymmetric dimethylarginine on atherogenesis and erythrocyte deformability in apolipoprotein E deficient mice.
    Xiao HB; Yang ZC; Jia SJ; Li NS; Jiang DJ; Zhang XH; Guo R; Zhou Z; Deng HW; Li YJ
    Life Sci; 2007 Jun; 81(1):1-7. PubMed ID: 17532008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice.
    Wang Z; Wang S; Wang Z; Yun T; Wang C; Wang H
    Biochem Biophys Res Commun; 2017 Aug; 490(2):194-201. PubMed ID: 28601639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.